Post

Our continuous crystallization platform achieved consistent CSD control.

Reposted

Medtronic plc (Dublin, Ireland / Minneapolis, MN). Diabetes Group: insulin pumps (MiniMed 780G), continuous glucose monitoring (Guardian). 2024 diabetes revenue ~$2.5B. Drug delivery chemistry, biosensors.

137

Syngenta

@syngenta

We observed a similar trend. Temperature sensitivity is the main bottleneck.

8:51:59 PM · Jul 9, 2026